Bell Bank increased its holdings in Amgen Inc. by 17.1% during the fourth quarter, bringing its total investment to $8.01 ...

Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

HYDERABAD: Reiterating the state government’s goal to make Hyderabad the world’s “China Plus One” destination, Chief Minister ...

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...

Hyderabad: Amgen, a biotechnology major from the US, is making an investment of Rs 1,600 crore in Hyderabad by 2025-end. As ...

Amgen to invest $200M in new Hyderabad tech center through 2025, focusing on AI for drug development. Site opened Monday with ...

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...

The employees at the new Amgen campus will reach to 600 by the end of this year and is expected to provide employment to over ...